SLGL
Sol-Gel Technologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$60.00
−7.03%Next report
Analyst consensus
- Next report date
- Nov 19, 2026
- EPS estimate
- -$2.36
- Revenue estimate
- $200.0K
Latest reported
- Last report date
- Aug 20, 2026
- EPS actual
- -$1.13
- EPS estimate
- -$2.36
- Revenue actual
- $591.0K
- Revenue estimate
- $75.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -67.5%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $198
- PT range
- $110 – $285
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 20, 2026 | -$2.36 | -$1.13 | Beat 52.12% | $591.0K |
| May 28, 2026 | -$2.86 | -$1.31 | Beat 54.20% | $108.0K |
| Mar 19, 2026 | $0.39 | -$1.07 | Miss -374.36% | $6.5M |
| Nov 20, 2025 | -$2.09 | -$2.13 | Miss -1.91% | $400.0K |
| Aug 15, 2025 | -$0.67 | $4.17 | Beat 722.39% | $17.3M |
| Apr 29, 2025 | -$1.10 | -$2.10 | Miss -90.91% | $1.0M |
| Mar 26, 2025 | -$0.11 | -$0.21 | Miss -90.77% | $278.0K |
| Nov 15, 2024 | -$0.13 | -$0.01 | Beat 92.31% | $5.4M |
| Aug 16, 2024 | -$0.20 | $0.07 | Beat 135.00% | $5.4M |
| May 20, 2024 | -$0.15 | -$0.23 | Miss -53.33% | $466.0K |
| Mar 13, 2024 | -$0.16 | -$0.17 | Miss -6.25% | $447.0K |
| Nov 9, 2023 | -$0.23 | -$0.21 | Beat 8.70% | $213.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026